Paul R. Johnston - 23 May 2024 Form 4 Insider Report for EXPONENT INC (EXPO)

Role
Director
Signature
By: Wendy Whitehouse For: Paul R. Johnston
Issuer symbol
EXPO
Transactions as of
23 May 2024
Net transactions value
-$396,362
Form type
4
Filing time
24 May 2024, 14:59:58 UTC
Previous filing
09 Jun 2023
Next filing
30 May 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EXPO Common Stock Options Exercise $74,310 +2,558 +3.2% $29.05 81,794 23 May 2024 Direct
transaction EXPO Common Stock Sale $243,292 -2,558 -3.1% $95.11 79,236 23 May 2024 Direct
transaction EXPO Common Stock Options Exercise $99,990 +3,442 +4.3% $29.05 82,678 23 May 2024 Direct
transaction EXPO Common Stock Sale $327,370 -3,442 -4.2% $95.11 79,236 23 May 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EXPO Incentive Stock Option (right to buy) Options Exercise -3,442 -100% 0 23 May 2024 Common Stock 3,442 $29.05 Direct F1, F2, F3
transaction EXPO Non-Qualified Stock Option (right to buy) Options Exercise -2,558 -5.7% 42,000 23 May 2024 Common Stock 2,558 $29.05 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Per 10b5-1 trading plan entered into on Feb. 2, 2024.
F2 The stock option becomes exercisable in four equal annual installments.
F3 Not applicable.